Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26FU964
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,000
Award facts
- Contract value 100% obligated
- $25,999.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits. This competitive, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. CIMZIA is a TNF inhibitor immunosuppressant used primarily to treat inflammatory conditions including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease, making it a critical pharmaceutical commodity for federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle running through December 2026. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's award demonstrates its continued capability to meet federal procurement requirements through open competition and underscores its role as a primary vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FU964?
SPE2DR26FU964 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FU964 worth?
The government has obligated $26,000 on SPE2DR26FU964.
Is contract SPE2DR26FU964 an order under another contract?
Yes. SPE2DR26FU964 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU964 competed?
The extent of competition for SPE2DR26FU964 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award